Oxford Nanopore Technologies 

€9.17
108
-€0.06-0.65% 08:55 今天

統計

當日最高
9.19
當日最低
9.17
52週高點
9.25
52週低點
7.45
成交量
-
平均成交量
-
市值
8.94B
本益比
-
股息殖利率
-
股息
-

即將到來

財報

8月19日預期
Q2 2026
-0.08
-0.07
-0.06
-0.06
預期EPS
-0.07604558935450201
實際EPS
-0.055642837194

財務

-64.87%利潤率
未盈利
2020
2021
2022
2023
2024
2025
258.61M營收
-167.77M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 4R00.F 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Oxford Nanopore Technologies plc, founded in 2005 and originally known as Oxford NanoLabs Limited before its name change in May 2008, is a United Kingdom-based enterprise that specializes in developing and commercializing an innovative system for analyzing diverse molecular structures through nanopore-based sensing. Its product range features a variety of devices, including the portable MinION for sequencing deoxyribonucleic acid and ribonucleic acid, and the MinION Mk1C, which integrates basecalling, data analysis, touchscreen controls, and wireless connectivity. For benchtop operations, the company offers the GridION, capable of running and analyzing up to five MinION or Flongle flow cells, as well as the GridION Mk1 nanopore sequencer. High-yield sequencing is made accessible with the PromethION 2 Solo and PromethION 2, while the PromethION 24 and PromethION 48 provide benchtop nanopore sequencers for multiple users to achieve multi-sample and multi-experiment results. Further complementing these devices are Flongle, an adapter for MinION or GridION units, and VolTRAX, a USB-powered tool designed to automate laboratory processes preceding nanopore sequencing. The company also provides a suite of software solutions: MinKNOW facilitates data acquisition, real-time analysis and feedback, local basecalling, and data streaming; specialized Basecalling tools pinpoint the identity and sequence of bases on DNA/RNA molecules; EPI2ME is a cloud-based platform for comprehensive, real-time analysis of nanopore data; and EPI2ME Labs offers bioinformatics support to help users refine their skills and confidence in analyzing their sequencing data. Additionally, Oxford Nanopore Technologies is actively developing new products such as MinION Mk1D, Ubi, Plongle, and SmidgION. All of its products are available for purchase online.
顯示更多
執行長
Francis Albert Luc Van Parys
員工
1314
國家
英國
ISIN
US69166E1047
WKN
000A3DZUG

上市

0 則留言

分享你的想法

常見問題

Oxford Nanopore Technologies 今天的股價是多少?▼
4R00.F 目前價格為 €9.17 EUR,過去 24 小時下跌了 -0.65%。在圖表上更密切關注 Oxford Nanopore Technologies 股票的表現。
Oxford Nanopore Technologies 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Frankfurt Exchange 交易所,Oxford Nanopore Technologies 的股票以代號 4R00.F 進行交易。
Oxford Nanopore Technologies 的市值是多少?▼
今天 Oxford Nanopore Technologies 的市值為 8.94B
Oxford Nanopore Technologies 下一次財報日期是什麼時候?▼
Oxford Nanopore Technologies 將於 2027年3月9日 公布下一次財報。
Oxford Nanopore Technologies 上一季度的財報如何?▼
4R00.F 上一季度的財報為每股 -0.06 EUR,預估為 -0.08 EUR,帶來 +26.83% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Oxford Nanopore Technologies 去年的營收是多少?▼
Oxford Nanopore Technologies 去年的營收為 258.61MEUR。
Oxford Nanopore Technologies 去年的淨利是多少?▼
4R00.F 去年的淨收益為 -167.77MEUR。
Oxford Nanopore Technologies 有多少名員工?▼
截至 2026年11月2日,公司共有 1,314 名員工。
Oxford Nanopore Technologies 位於哪個產業?▼
Oxford Nanopore Technologies從事於Health & Wellness產業。
Oxford Nanopore Technologies 何時完成拆股?▼
Oxford Nanopore Technologies 最近沒有進行任何拆股。
Oxford Nanopore Technologies 的總部在哪裡?▼
Oxford Nanopore Technologies 的總部位於 英國 的 Oxford。